Natrol
This article was originally published in The Tan Sheet
Executive Summary
Net loss of $521,000 for the third quarter attributed to softening market, "higher than normal" returns from retailers seeking to adjust inventory and increased promotional costs to forestall returns, Chatsworth, Calif.-based company reports Nov. 6. In comparison, Natrol's net income reached $2.5 mil. in the year-ago quarter. Three-month sales rose 5.2% to $22.3 mil. In May, the company said it would back the launch of CetylPure joint health supplement with $2.5 mil. in advertising (1"The Tan Sheet" May 8, p. 5). Overall, nine-month sales increased 21.4% to $69.1 mil., with the Prolab sports nutrition division, acquired in October 1999, accounting for $18 mil
You may also be interested in...
Natrol CetylPure $2.5 Mil. Ad Campaign, Broad Distribution Underway
Natrol will support its patented CetylPure joint health supplement with at least $2.5 mil. in advertising support this year, the company said.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands